Cargando…

Targetome analysis of chaperone-mediated autophagy in cancer cells

Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undert...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yuqing, Kacal, Merve, Ouchida, Amanda Tomie, Zhang, Boxi, Norberg, Erik, Vakifahmetoglu-Norberg, Helin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693453/
https://www.ncbi.nlm.nih.gov/pubmed/30821613
http://dx.doi.org/10.1080/15548627.2019.1586255
_version_ 1783443710035361792
author Hao, Yuqing
Kacal, Merve
Ouchida, Amanda Tomie
Zhang, Boxi
Norberg, Erik
Vakifahmetoglu-Norberg, Helin
author_facet Hao, Yuqing
Kacal, Merve
Ouchida, Amanda Tomie
Zhang, Boxi
Norberg, Erik
Vakifahmetoglu-Norberg, Helin
author_sort Hao, Yuqing
collection PubMed
description Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40.
format Online
Article
Text
id pubmed-6693453
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-66934532019-08-26 Targetome analysis of chaperone-mediated autophagy in cancer cells Hao, Yuqing Kacal, Merve Ouchida, Amanda Tomie Zhang, Boxi Norberg, Erik Vakifahmetoglu-Norberg, Helin Autophagy Research Paper Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40. Taylor & Francis 2019-03-20 /pmc/articles/PMC6693453/ /pubmed/30821613 http://dx.doi.org/10.1080/15548627.2019.1586255 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Paper
Hao, Yuqing
Kacal, Merve
Ouchida, Amanda Tomie
Zhang, Boxi
Norberg, Erik
Vakifahmetoglu-Norberg, Helin
Targetome analysis of chaperone-mediated autophagy in cancer cells
title Targetome analysis of chaperone-mediated autophagy in cancer cells
title_full Targetome analysis of chaperone-mediated autophagy in cancer cells
title_fullStr Targetome analysis of chaperone-mediated autophagy in cancer cells
title_full_unstemmed Targetome analysis of chaperone-mediated autophagy in cancer cells
title_short Targetome analysis of chaperone-mediated autophagy in cancer cells
title_sort targetome analysis of chaperone-mediated autophagy in cancer cells
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693453/
https://www.ncbi.nlm.nih.gov/pubmed/30821613
http://dx.doi.org/10.1080/15548627.2019.1586255
work_keys_str_mv AT haoyuqing targetomeanalysisofchaperonemediatedautophagyincancercells
AT kacalmerve targetomeanalysisofchaperonemediatedautophagyincancercells
AT ouchidaamandatomie targetomeanalysisofchaperonemediatedautophagyincancercells
AT zhangboxi targetomeanalysisofchaperonemediatedautophagyincancercells
AT norbergerik targetomeanalysisofchaperonemediatedautophagyincancercells
AT vakifahmetoglunorberghelin targetomeanalysisofchaperonemediatedautophagyincancercells